What Is Stryker (SYK) Really Getting From Its $400 Million Robotics Deal?

Stryker (NYSE:SYK) agreed to invest US$400m in CMR Surgical in a deal focused on soft-tissue robotic surgery. The agreement grants Stryker exclusive U.S. rights to commercialize CMR's Versius robotic surgery platform. Stryker also secured an exclusive option to acquire CMR Surgical, extending its reach beyond orthopedics and MedSurg. The US$400m CMR Surgical deal, which includes U.S. Versius rights and an acquisition option, is only one piece of the Stryker story. We have also flagged 2...